Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10541004rdf:typepubmed:Citationlld:pubmed
pubmed-article:10541004lifeskim:mentionsumls-concept:C0058698lld:lifeskim
pubmed-article:10541004lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:10541004lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:10541004lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:10541004lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:10541004lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:10541004pubmed:issue1lld:pubmed
pubmed-article:10541004pubmed:dateCreated1999-11-30lld:pubmed
pubmed-article:10541004pubmed:abstractTextGenetic factors and dopamine receptor dysfunction have been implicated in the pathophysiology of schizophrenia. Recently, an association between a putative functional promoter polymorphism (-141C Ins/Del) in the dopamine D2 receptor gene and schizophrenia was reported. We investigated unrelated Swedish schizophrenic patients (n = 129) and control subjects (n = 179) for the same polymorphism. Similarly to a previous Japanese report, the - 141C Del allele frequency was significantly lower in patients than controls (chi2=4.4, 1 df, p<0.05; odds ratio 0.49, 95% confidence interval 0.26-0.91). The present and previous results may indicate that the -141C Ins/Del dopamine D2 receptor gene polymorphism affects susceptibility to schizophrenia.lld:pubmed
pubmed-article:10541004pubmed:languageenglld:pubmed
pubmed-article:10541004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10541004pubmed:citationSubsetIMlld:pubmed
pubmed-article:10541004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10541004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10541004pubmed:statusMEDLINElld:pubmed
pubmed-article:10541004pubmed:monthNovlld:pubmed
pubmed-article:10541004pubmed:issn0920-9964lld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:AsbergMMlld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:ProppingPPlld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:SedvallG CGClld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:ForslundKKlld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:RylanderGGlld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:NöthenM MMMlld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:Mattila-Evend...lld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:JönssonE GEGlld:pubmed
pubmed-article:10541004pubmed:authorpubmed-author:NeidtHHlld:pubmed
pubmed-article:10541004pubmed:issnTypePrintlld:pubmed
pubmed-article:10541004pubmed:day9lld:pubmed
pubmed-article:10541004pubmed:volume40lld:pubmed
pubmed-article:10541004pubmed:ownerNLMlld:pubmed
pubmed-article:10541004pubmed:authorsCompleteYlld:pubmed
pubmed-article:10541004pubmed:pagination31-6lld:pubmed
pubmed-article:10541004pubmed:dateRevised2010-9-2lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:meshHeadingpubmed-meshheading:10541004...lld:pubmed
pubmed-article:10541004pubmed:year1999lld:pubmed
pubmed-article:10541004pubmed:articleTitleAssociation between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.lld:pubmed
pubmed-article:10541004pubmed:affiliationDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. erikj@psyk.ks.selld:pubmed
pubmed-article:10541004pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10541004pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10541004lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10541004lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10541004lld:pubmed